Aveanna Healthcare (NASDAQ:AVAH) Price Target Raised to $12.50

Aveanna Healthcare (NASDAQ:AVAH) had its price target lifted by Jefferies Financial Group from $11.00 to $12.50 in a research report sent to investors on Tuesday,Benzinga reports. They currently have a buy rating on the stock.

Several other research analysts have also weighed in on the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Aveanna Healthcare in a research report on Wednesday, October 8th. JPMorgan Chase & Co. raised Aveanna Healthcare from an “underweight” rating to a “neutral” rating and upped their target price for the stock from $6.00 to $10.00 in a research report on Thursday, September 18th. Wall Street Zen raised Aveanna Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 9th. Zacks Research downgraded Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 20th. Finally, Barclays upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $5.50 to $9.50 in a research note on Tuesday, August 19th. Three research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $9.29.

Aveanna Healthcare Stock Down 5.3%

Shares of Aveanna Healthcare stock opened at $9.34 on Tuesday. The stock’s fifty day moving average is $8.70 and its 200-day moving average is $6.30. The firm has a market capitalization of $1.95 billion, a PE ratio of 116.75 and a beta of 2.05. Aveanna Healthcare has a 12-month low of $3.67 and a 12-month high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last released its earnings results on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. Aveanna Healthcare had a negative return on equity of 54.56% and a net margin of 0.85%.The company had revenue of $450.53 million for the quarter. Analysts expect that Aveanna Healthcare will post -0.06 EPS for the current year.

Insider Activity at Aveanna Healthcare

In related news, major shareholder J.H. Whitney Equity Partners V sold 8,346,059 shares of the firm’s stock in a transaction that occurred on Tuesday, October 21st. The stock was sold at an average price of $9.00, for a total transaction of $75,114,531.00. Following the completion of the transaction, the insider owned 20,544,696 shares in the company, valued at $184,902,264. This trade represents a 28.89% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Robert M. Williams, Jr. sold 10,000,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 21st. The stock was sold at an average price of $9.00, for a total value of $90,000,000.00. Following the transaction, the insider owned 386,284 shares of the company’s stock, valued at $3,476,556. This trade represents a 96.28% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 32,597,968 shares of company stock worth $293,381,712. 7.80% of the stock is owned by corporate insiders.

Institutional Trading of Aveanna Healthcare

Several large investors have recently made changes to their positions in the business. Teacher Retirement System of Texas increased its stake in shares of Aveanna Healthcare by 50.9% in the 1st quarter. Teacher Retirement System of Texas now owns 49,881 shares of the company’s stock valued at $270,000 after buying an additional 16,835 shares during the period. Bank of New York Mellon Corp grew its stake in shares of Aveanna Healthcare by 4.2% during the first quarter. Bank of New York Mellon Corp now owns 114,881 shares of the company’s stock worth $623,000 after purchasing an additional 4,655 shares during the period. Cornerstone Investment Partners LLC acquired a new stake in shares of Aveanna Healthcare during the first quarter worth $167,000. Mackenzie Financial Corp grew its stake in shares of Aveanna Healthcare by 145.9% during the first quarter. Mackenzie Financial Corp now owns 263,662 shares of the company’s stock worth $1,429,000 after purchasing an additional 156,439 shares during the period. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its stake in Aveanna Healthcare by 159.9% in the first quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 65,414 shares of the company’s stock valued at $355,000 after buying an additional 40,243 shares during the period. Institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.